M4MM
Portugal Medical Cannabis Outpaces 2025 Export Run Rate
LISBON – Portugal's medicines regulator, Infarmed, has confirmed that the country exported 66,305 kilograms of medical Cannabis between January and June 2026, equivalent to more than 80% of everything it shipped in all of 2025. ...
UMiami Hands Over Its 1994 Ibogaine Research to Washington
LOS ANGELES – The University of Miami has donated its original 1994 investigational new drug (IND) application for ibogaine to the federal government, giving Washington direct operational authority over the foundational FDA authorization that made ...
CRB Monitor and NCS Analytics Partner to Bridge the Cannabis Compliance Data Gap
DENVER – Two of the industry's most data-intensive platforms that have long operated on parallel tracks in the Cannabis compliance space announced a formal partnership, combining regulatory licensing records with real-time operational analytics into a ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The final days of July and the opening of August delivered a concentrated burst of news that touched labor, capital markets, federal regulation, and cross-border insolvency. A historic labor settlement, a one-company ...
MJBowl Adds Colorado for Its Second Year
LOS ANGELES – The MJBowl, the Cannabis product competition co-presented by MJBizCon and professional review platform Budist, is returning for its second year, with Colorado joining California and New York in the competition pool for ...
FDA Issues Final Guidance on Psychedelic Drug Trials
SILVER SPRING – The FDA published its final guidance titled "Psychedelic Drugs: Considerations for Clinical Investigations" in the Federal Register, finalizing a draft that first appeared in June 2023. Issued by the Center for Drug ...
Vireo Growth Re-Enters Ohio Through Four Concurrent Deals
MINNEAPOLIS – Vireo Growth Inc. announced that it has signed four separate Securities Purchase Agreements to acquire all membership interests of FarmaceuticalRx LLC, FarmaceuticalRx 2 LLC, CAOH LLC, and Canoe Hill Ohio, LLC. The four ...
Portugal Medical Cannabis Outpaces 2025 Export Run Rate
LISBON – Portugal's medicines regulator, Infarmed, has confirmed that the country exported 66,305 kilograms of medical Cannabis between January and June 2026, equivalent to more than 80% of everything it shipped in all of 2025. ...
UMiami Hands Over Its 1994 Ibogaine Research to Washington
LOS ANGELES – The University of Miami has donated its original 1994 investigational new drug (IND) application for ibogaine to the federal government, giving Washington direct operational authority over the foundational FDA authorization that made ...
CRB Monitor and NCS Analytics Partner to Bridge the Cannabis Compliance Data Gap
DENVER – Two of the industry's most data-intensive platforms that have long operated on parallel tracks in the Cannabis compliance space announced a formal partnership, combining regulatory licensing records with real-time operational analytics into a ...
Texas Regulator Awards Verano Conditional License to Operate in State’s Medical Cannabis Market
AUSTIN – The Texas Department of Public Safety has issued a conditional license to Verano Texas, LLC, a subsidiary of Verano Holdings Corp., paving the way for the MSO to pursue cultivation, processing, and retail ...
Sensi Brands Secures Major Cultivation Site in Bid for Overseas Expansion
RICHMOND HILL – Sensi Brands Inc. completed its purchase of Maricann Inc., gaining control of a sprawling production facility tailored for export markets. The deal, the company's biggest to date, centers on a 100-acre campus ...
High Tide Launches Europe’s First Canna Cabana Store in Berlin
BERLIN – High Tide Inc., the Calgary-based Cannabis retailer known for its discount club model, has cut the ribbon on its inaugural European outpost, a Canna Cabana store in central Berlin that sells accessories and ...
Conservative Think Tank Advocates Federal Cannabis Labeling Standards to Address State Disparities
WASHINGTON – A prominent conservative policy group has called for federal guidance on Cannabis product warnings, pointing to stark differences in state regulations that leave consumers with inconsistent information on health risks. The American Enterprise ...
Psyence BioMed Ventures into Psilocybin’s Role in Aging Research
NEW YORK – Psyence BioMedical Ltd. disclosed its entry into longevity science with a new program probing psilocybin's influence on key aging indicators. The initiative, conducted alongside South African academics, marks the company's first foray ...
Kenyan MP Advocates for Regulated Cannabis Framework
NAIROBI – Peter Kalerwa Salasya, the outspoken member of Parliament for Kenya's Mumias East constituency, has ignited fresh debate on Сannabis policy by urging the government to pursue legalization under strict controls. Salasya highlighted the ...
OPINION: The Looming Federal Clampdown on THC Drinks and Hemp-Derived Edibles: What It Means for the Industry
NEW YORK- The quiet addition of a single paragraph in November’s federal shutdown bill has sent shockwaves through one of the fastest-growing segments of U.S. Cannabis: hemp-derived THC beverages and edibles. Unless Congress intervenes, a ...
Tilray Executes 1-for-10 Reverse Stock Split to Trim Shares and Cut Costs
NEW YORK – Tilray Brands Inc. confirmed it will carry out a 1-for-10 reverse stock split on its common shares, a step shareholders greenlit back in June to help the company meet Nasdaq listing standards ...
New York State OCM Updates Medical Cannabis Program, Expands Access for Out-of-State Patients
ALBANY – Governor Kathy Hochul signed a bill into law that extends New York's medical Cannabis program to patients certified in other states, marking the most substantial revision to the initiative since its 2016 launch. ...
New Brunswick Government Bets on Organigram with $2M Grant
MONCTON – Organigram Global Inc. has secured $2 million in provincial funding to support a $9.3 million project aimed at revamping its flagship cultivation site here. The upgrade, which targets lighting systems across 75 grow ...
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...
Medicare Explores CBD Coverage for Seniors
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) is set to roll out a pilot program that could extend coverage to cannabidiol (CBD) treatments for certain older Americans, marking a cautious step by ...
How to Make the Most of MJBizCon? Take Full Advantage of LinkedIn
LOS ANGELES- Each year, the global Cannabis industry converges on Las Vegas for MJBizCon Dec 2-5 in the Las Vegas Convention Center—a concentrated, high-value moment where operators, investors, executives, retailers, lenders, lawyers, accountants, manufacturers, and ...
New Jersey Assembly Panel Clears Path for Psilocybin Therapy Program
TRENTON – New Jersey lawmakers advanced a bill that would allow supervised access to psilocybin for adults facing certain health challenges, establishing a regulated psilocybin therapy framework approved by the Assembly Health Committee. Assemblymember Anthony ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators and investors in Cannabis and Psychedelics faced a week of sharp contrasts. Federal action ended the longest government shutdown on record, yet it delivered a body blow to hemp-derived products that ...
